SPOTLIGHT: Does the patent cliff drive innovation?

Is generic competition good for the biotech and pharma industries? An article from The San Francisco Chronicle argues that as aging drugs go off patent, companies are forced to push innovation to new heights in an effort to render older drugs obsolete. Article